Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 891-898

  Lavanya, Madakasira ^a   Kinet, Sandrina ^a   Montel Hagen, Amélie ^a   Mongellaz, Cédric ^a   Battini, Jean Luc ^a   Sitbon, Marc ^a   Taylor, Naomi ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE LEUKEMIA VIRUS RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 7; UNCLASSIFIED DRUG; VIRUS RECEPTOR; BLVR PROTEIN, BOS TAURUS; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; BOVINE LEUKEMIA VIRUS; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; THYMOCYTE; THYMUS; ANIMAL; CATTLE; CELL CULTURE; CHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN TERTIARY STRUCTURE; RABBIT; RETROVIRUS; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CATTLE; CELL LINE, TUMOR; CELLS, CULTURED; DELTARETROVIRUS; HUMANS; INTERLEUKIN-7; LEUKEMIA VIRUS, BOVINE; LYMPHOCYTE ACTIVATION; MICE; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; THYMUS GLAND; UP-REGULATION; VIRAL ENVELOPE PROTEINS;

EID: 49049100737     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.891     Document Type: Article

References (63)

1. Schwartz, I., A. Bensaid, B. Polack, B. Perrin, M. Berthelemy, and D. Levy. 1994. In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle. J. Virol. 68: 4589-4596. (Pubitemid 24183056)
2. Wu, D., K. Takahashi, K. Murakami, K. Tani, A. Koguchi, M. Asahina, M. Goryo, Y. Aida, and K. Okada. 1996. B-1a, B-1b and conventional B cell lymphoma from enzootic bovine leukosis. Vet. Immunol. Immunopathol. 55: 63-72. (Pubitemid 27041593)
3. Saini, S. S., B. Allore, R. M. Jacobs, and A. Kaushik. 1999. Exceptionally long CDR3H region with multiple cysteine residues in functional bovine IgM antibodies. Eur. J. Immunol. 29: 2420-2426.
4. Gillet, N., A. Florins, M. Boxus, C. Burteau, A. Nigro, F. Vandermeers, H. Balon, A. B. Bouzar, J. Defoiche, A. Burny, et al. 2007. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 4: 18. (Pubitemid 46510394)
5. Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. van den Broeke, L. Willems, and R. Thomas. 1988. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet. Microbiol. 17: 197-218. (Pubitemid 18222709)
6. Schwartz-Cornil, I., N. Chevallier, C. Belloc, D. Le Rhun, V. Laine, M. Berthelemy, A. Mateo, and D. Levy. 1997. Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B cell apoptosis. J. Gen. Virol. 78: 153-162. (Pubitemid 27067526)
7. Dequiedt, F., G. H. Cantor, V. T. Hamilton, S. M. Pritchard, W. C. Davis, P. Kerkhofs, A. Burny, R. Kettmann, and L. Willems. 1999. Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes. J. Virol. 73: 1127-1137. (Pubitemid 29036764)
8. Debacq, C., N. Gillet, B. Asquith, M. T. Sanchez-Alcaraz, A. Florins, M. Boxus, I. Schwartz-Cornil, M. Bonneau, G. Jean, P. Kerkhofs, et al. 2006. Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J. Virol. 80: 9710-9719. (Pubitemid 44435645)
9. Debacq, C., B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems. 2002. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA 99: 10048-10053. (Pubitemid 34831170)
10. Rovnak, J., J. W. Casey, A. L. Boyd, M. A. Gonda, and G. L. Cockerell. 1991. Isolation of bovine leukemia virus infected endothelial cells from cattle with persistent lymphocytosis. Lab. Invest. 65: 192-202.
11. Heeney, J. L., P. J. Valli, R. M. Jacobs, and V. E. Valli. 1992. Evidence for bovine leukemia virus infection of peripheral blood monocytes and limited antigen expression in bovine lymphoid tissue. Lab. Invest. 66: 608-617.
12. Buehring, G. C., P. M. Kramme, and R. D. Schultz. 1994. Evidence for bovine leukemia virus in mammary epithelial cells of infected cows. Lab. Invest. 71: 359-365.
13. Domenech, A., J. Goyache, L. Llames, M. Jesus Paya, G. Suarez, and E. Gomez-Lucia. 2000. In vitro infection of cells of the monocytic/macrophage lineage with bovine leukaemia virus. J. Gen. Virol. 81: 109-118. (Pubitemid 30047912)
14. Wu, D., K. Murakami, A. Morooka, H. Jin, Y. Inoshima, and H. Sentsui. 2003. In vivo transcription of bovine leukemia virus and bovine immunodeficiency-like virus. Virus Res. 97: 81-87. (Pubitemid 37352930)
15. Mirsky, M. L., C. A. Olmstead, Y. Da, and H. A. Lewin. 1996. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J. Virol. 70: 2178-2183.
16. Sagata, N., and Y. Ikawa. 1984. BLV and HTLV-I: their unique genomic structures and evolutionary relationship. Princess Takamatsu Symp. 15: 229-240.
17. Kim, F. J., I. Seiliez, C. Denesvre, D. Lavillette, F. L. Cosset, and M. Sitbon. 2000. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J. Biol. Chem. 275: 23417-23420.
18. Johnston, E. R., L. M. Albritton, and K. Radke. 2002. Envelope proteins containing single amino acid substitutions support a structural model of the receptorbinding domain of bovine leukemia virus surface protein. J. Virol. 76: 10861-10872.
19. Kim, F. J., N. Manel, E. N. Garrido, C. Valle, M. Sitbon, and J. L. Battini. 2004. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology 1: 41.
20. Fass, D., R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger. 1997. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277: 1662-1666. (Pubitemid 27446228)
21. Callebaut, I., J. P. Mornon, A. Burny, and D. Portetelle. 1994. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data. Leukemia 8(Suppl. 1): S218-S221. (Pubitemid 24979460)
22. Kobe, B., R. J. Center, B. E. Kemp, and P. Poumbourios. 1999. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltosebinding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. USA 96: 4319-4324. (Pubitemid 29190334)
23. Johnston, E. R., and K. Radke. 2000. The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions. J. Virol. 74: 2930-2935.
24. Manel, N., J. L. Battini, N. Taylor, and M. Sitbon. 2005. HTLV-1 tropism and envelope receptor. Oncogene 24: 6016-6025.
25. Ban, J., D. Portetelle, C. Altaner, B. Horion, D. Milan, V. Krchnak, A. Burny, and R. Kettmann. 1993. Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J. Virol. 67: 1050-1057. (Pubitemid 23032085)
26. Suzuki, T., Y. Matsubara, H. Kitani, and H. Ikeda. 2003. Evaluation of the δ subunit of bovine adaptor protein complex 3 as a receptor for bovine leukaemia virus. J. Gen. Virol. 84: 1309-1316. (Pubitemid 36592625)
27. Sommerfelt, M. A. 1999. Retrovirus receptors. J. Gen. Virol. 80: 3049-3064.
28. Manel, N., S. Kinet, J. L. Battini, F. J. Kim, N. Taylor, and M. Sitbon. 2003. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101: 1913-1918. (Pubitemid 36237593)
29. Manel, N., F. J. Kim, S. Kinet, N. Taylor, M. Sitbon, and J. L. Battini. 2003. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449-459. (Pubitemid 37456807)
30. Manel, N., J. L. Battini, and M. Sitbon. 2005. Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1. J. Biol. Chem. 280: 29025-29029. (Pubitemid 41161351)
31. Kinet, S., L. Swainson, M. Lavanya, C. Mongellaz, A. Montel-Hagen, M. Craveiro, N. Manel, J. L. Battini, M. Sitbon, and N. Taylor. 2007. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 4: 31. (Pubitemid 46851577)
32. Tailor, C. S., D. Lavillette, M. Marin, and D. Kabat. 2003. Cell surface receptors for gammaretroviruses. Curr. Top. Microbiol. Immunol. 281: 29-106.
33. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176: 58-69.
34. Battini, J. L., J. E. Rasko, and A. D. Miller. 1999. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G proteincoupled signal transduction. Proc. Natl. Acad. Sci. USA 96: 1385-1390.
35. Mueckler, M. 1994. Facilitative glucose transporters. Eur. J. Biochem. 219: 713-725.
36. Montel-Hagen, A., S. Kinet, N. Manel, C. Mongellaz, R. Prohaska, J. L. Battini, J. Delaunay, M. Sitbon, and N. Taylor. 2008. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell 132: 1039-1048.
37. Jassal, S. R., R. G. Pohler, and D. W. Brighty. 2001. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. J. Virol. 75: 8317-8328. (Pubitemid 32743704)
38. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70: 7322-7326.
39. Derse, D., and L. Martarano. 1990. Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity. J. Virol. 64: 401-405. (Pubitemid 20032641)
40. Ahern, T., J. Sampson, and J. E. Kay. 1974. Initiation of protein synthesis during lymphocyte stimulation. Nature 248: 519-521.
41. Varesio, L., and H. T. Holden. 1980. Mechanisms of lymphocyte activation: linkage between early protein synthesis and late lymphocyte proliferation. J. Immunol. 124: 2288-2294. (Pubitemid 10113321)
42. Hassan, J., and D. J. Reen. 1998. IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur. J. Immunol. 28: 3057-3065. (Pubitemid 28470251)
43. + T cells enables preservation of a naive repertoire. J. Immunol. 161: 5909-5917.
44. Nath, M. D., F. W. Ruscetti, C. Petrow-Sadowski, and K. S. Jones. 2003. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood 101: 3085-3092.
45. Ghez, D., Y. Lepelletier, S. Lambert, J. M. Fourneau, V. Blot, S. Janvier, B. Arnulf, P. M. van Endert, N. Heveker, C. Pique, and O. Hermine. 2006. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80: 6844-6854. (Pubitemid 44025184)
46. Jones, K. S., K. Fugo, C. Petrow-Sadowski, Y. Huang, D. C. Bertolette, I. Lisinski, S. W. Cushman, S. Jacobson, and F. W. Ruscetti. 2006. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80: 8291-8302.
47. Boomer, S., M. Eiden, C. C. Burns, and J. Overbaugh. 1997. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 71: 8116-8123. (Pubitemid 27446386)
48. Faix, P. H., S. A. Feldman, J. Overbaugh, and M. V. Eiden. 2002. Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain. J. Virol. 76: 12369-12375.
49. Gemeniano, M., O. Mpanju, D. R. Salomon, M. V. Eiden, and C. A. Wilson. 2006. The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology 346: 108-117. (Pubitemid 43254703)
50. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
51. Chakrabarti, R., C. Y. Jung, T. P. Lee, H. Liu, and B. K. Mookerjee. 1994. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J. Immunol. 152: 2660-2668. (Pubitemid 24097960)
52. Rathmell, J. C., R. L. Elstrom, R. M. Cinalli, and C. B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33: 2223-2232.
53. Rathmell, J. C., M. G. Vander Heiden, M. H. Harris, K. A. Frauwirth, and C. B. Thompson. 2000. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6: 683-692.
54. Trowbridge, I. S., and D. A. Shackelford. 1986. Structure and function of transferrin receptors and their relationship to cell growth. Biochem. Soc. Symp. 51: 117-129.
55. Brekelmans, P., P. van Soest, J. Voerman, P. P. Platenburg, P. J. Leenen, and W. van Ewijk. 1994. Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse. Cell. Immunol. 159: 331-339. (Pubitemid 24381061)
56. Macedo, M. F., M. de Sousa, R. M. Ned, C. Mascarenhas, N. C. Andrews, and M. Correia-Neves. 2004. Transferrin is required for early T-cell differentiation. Immunology 112: 543-549.
57. Lindsten, T., C. H. June, C. B. Thompson, and J. M. Leiden. 1988. Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol. Cell. Biol. 8: 3820-3826. (Pubitemid 18217948)
58. Gottesdiener, K. M., B. A. Karpinski, T. Lindsten, J. L. Strominger, N. H. Jones, C. B. Thompson, and J. M. Leiden. 1988. Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Mol. Cell. Biol. 8: 3809-3819.
59. Kelly, A. P., D. K. Finlay, H. J. Hinton, R. G. Clarke, E. Fiorini, F. Radtke, and D. A. Cantrell. 2007. Notch-induced T cell development requires phosphoinositide- dependent kinase 1. EMBO J. 26: 3441-3450.
60. + human thymocytes with high CXCR4-induced chemotaxis. Proc. Natl. Acad. Sci. USA 102: 12867-12872.
61. Van De Wiele, C. J., J. H. Marino, B. W. Murray, S. S. Vo, M. E. Whetsell, and T. K. Teague. 2004. Thymocytes between the β-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. J. Immunol. 172: 4235-4244.
62. Munitic, I., J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, and J. D. Ashwell. 2004. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 104: 4165-4172. (Pubitemid 39620170)
63. Yu, Q., B. Erman, J. H. Park, L. Feigenbaum, and A. Singer. 2004. IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORγt: impact on thymocyte development. J. Exp. Med. 200: 797-803. (Pubitemid 39299465)